Ardabil University of Medical Sciences
Digestive Disease Research Center
Principal Investigator: Dr. Farhad Pourfarzi
Professor of Community Medicine, Ardabil Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Approval date
17 March 2016
Starting date
13 May 2017
Goals
Main objectives A) To determine the incidence of major NCDs in people aged 35-69 years B) To identify and measure the association between risk factors and GC C) To determine the etiology of GI cancers D) To stablish a Biobank for collected samples
Study population
All eligible people aged between ages of 35 and 69 living in Ardabil County
Sampling method and sample size
Convenient sampling method was used to recruit 10,000 resident of Ardabil city
Data Collection
All data were collected based on the Persian cohort protocol. People were interviewed in center to collect data about all risk factors of non-communicable diseases including Socio-economic status and lifestyle, Environmental and occupational exposures, General health and medical and family history, Anthropometric measurements, Reproductive history, Dietary habits. All the above-mentioned exposures collected using an internet-based questionnaire. Meanwhile blood, urine, hair and nail samples have been collected and kept in ultra-freezer.
Follow up Methods
Participants will be actively followed every 4 months. Additionally, a full assessment (as in the enrollment phase) will take place in two stages in a period of 5 years. In active follow up, each participant will be contacted by phone. Annual reports from diseases and deaths records will also be reviewed.
Main Exposures
all risk factors of non-communicable diseases including: a. Socio-economic status and lifestyle b. Environmental and occupational exposures c. General health and medical and family history d. Anthropometric measurements e. Reproductive history f. Dietary habits
Outcomes
cardiovascular diseases, cerebrovascular accidents, cancers, diabetes mellitus, chronic pulmonary diseases, chronic kidney disease leading to dialysis, cirrhosis, Parkinson s and Alzheimer s diseases, hospital admission and deaths. In addition, Helicobacter pylori infection has been diagnosed using UBT and HP stool antigen.
Cohort Study
Gallery
17 March 2016
Approval date
13 May 2017
Starting date
13 May 2017
19 March 2020
End of enrollment phase
18 September 2021
Reassessment Date
Milestone Content goes here
18 September 2021